Hepatic carcinosarcoma with predominant sarcomatous component mimicking intrahepatic cholangiocarcinoma: a case report and literature review.
[BACKGROUND] Hepatic carcinosarcoma (HCS) is an extremely rare primary malignant liver tumor characterized by aggressive biological behavior, early invasion, and poor prognosis.
APA
Ji X, Fu M, Liu F (2026). Hepatic carcinosarcoma with predominant sarcomatous component mimicking intrahepatic cholangiocarcinoma: a case report and literature review.. Frontiers in medicine, 13, 1805372. https://doi.org/10.3389/fmed.2026.1805372
MLA
Ji X, et al.. "Hepatic carcinosarcoma with predominant sarcomatous component mimicking intrahepatic cholangiocarcinoma: a case report and literature review.." Frontiers in medicine, vol. 13, 2026, pp. 1805372.
PMID
42040540
Abstract
[BACKGROUND] Hepatic carcinosarcoma (HCS) is an extremely rare primary malignant liver tumor characterized by aggressive biological behavior, early invasion, and poor prognosis. Owing to its non-specific clinical manifestations and imaging features, preoperative diagnosis remains challenging.
[CASE REPORT] We report a 54-year-old man who presented with persistent fever and unexplained weight loss for 2 weeks. Imaging studies revealed a large space-occupying lesion in the right hepatic lobe, with a preliminary suspicion of cholangiocarcinoma. Liver biopsy findings suggested a sarcomatous lesion. Further computed tomography (CT) evaluation revealed a heterogeneous hypodense mass (11 cm) in the right liver, encircling the right portal vein branch and accompanied by mild bile duct dilatation. Laboratory tests showed normal levels of tumor markers including alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and carbohydrate antigen 125 (CA125). The patient subsequently underwent laparoscopic right hepatectomy and cholecystectomy. Postoperative pathology revealed extensive tumor necrosis with residual components consisting of approximately 30% poorly differentiated hepatocellular carcinoma and 70% sarcomatoid tissue, confirming the diagnosis of hepatic carcinosarcoma.
[CONCLUSION] Hepatic carcinosarcoma often presents with insidious and non-specific clinical and radiological features, resulting in frequent misdiagnosis. Complete resection remains the primary treatment modality. This case underscores the importance of integrating imaging, histopathology, and immunohistochemical analysis for confirming this rare tumor.
[CASE REPORT] We report a 54-year-old man who presented with persistent fever and unexplained weight loss for 2 weeks. Imaging studies revealed a large space-occupying lesion in the right hepatic lobe, with a preliminary suspicion of cholangiocarcinoma. Liver biopsy findings suggested a sarcomatous lesion. Further computed tomography (CT) evaluation revealed a heterogeneous hypodense mass (11 cm) in the right liver, encircling the right portal vein branch and accompanied by mild bile duct dilatation. Laboratory tests showed normal levels of tumor markers including alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and carbohydrate antigen 125 (CA125). The patient subsequently underwent laparoscopic right hepatectomy and cholecystectomy. Postoperative pathology revealed extensive tumor necrosis with residual components consisting of approximately 30% poorly differentiated hepatocellular carcinoma and 70% sarcomatoid tissue, confirming the diagnosis of hepatic carcinosarcoma.
[CONCLUSION] Hepatic carcinosarcoma often presents with insidious and non-specific clinical and radiological features, resulting in frequent misdiagnosis. Complete resection remains the primary treatment modality. This case underscores the importance of integrating imaging, histopathology, and immunohistochemical analysis for confirming this rare tumor.
같은 제1저자의 인용 많은 논문 (5)
- Mechanism of cancer-associated fibroblast-driven thyroid cancer dedifferentiation via the ZFP57-PKM2 axis-mediated lactate secretion and therapeutic intervention with resveratrol.
- Functional role of deubiquitinating enzyme USP39 in inhibiting pyroptosis in human acute myeloid leukemia.
- Replacing BPA: Structural Substitutes BPAF Binding to the Progesterone Receptor Elevates Breast Cancer Risk.
- Reductive stress in cancer immunology and targeted therapy.
- Pedicled versus free flap reconstruction in head and neck surgery: analysis of complications and quality of life.